# X4 Pharmaceuticals, Inc: Form 8-K, filed Apr 18, 2025

- Company: [X4 Pharmaceuticals, Inc](/companies/xfor.md) (CIK 1501697)
- Form: 8-K
- Filed: 2025-04-18
- Accepted by EDGAR: Apr 18, 2025, 16:18 ET
- Period: 2025-04-17
- Accession: 0001628280-25-018389
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501697/000162828025018389/xfor-20250417.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501697/000162828025018389/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501697/000162828025018389/xfor-20250417.htm

Filed Apr 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-018389. Last ingested by Listed: Nov 4, 2026, 16:53 ET. No prices; not investment advice.